Sanguina develops an AI application that screens for anemia using fingernail images, leveraging technology from Georgia Tech and Emory University. The company is based in Georgia and is part of a regional effort to bolster biomedical startups with local capital and expertise. Its recent financing from a syndicate including Emory BioFoundry Institute, Invest Georgia, and the Georgia Tech Research Impact Fund is intended to advance and market the AI app. Sanguina plans to use the investment to pursue FDA approval, improve data collection, and scale commercial operations. The coverage notes the company has previously raised $5.6 million. The startup is positioning its solution against a global anemia burden that affects nearly two billion people.

Total raised

$7M

Funding rounds

3

Latest round

Series A

Latest activity

Jul 2023